Global Trends
-
Biotech Acquirer Xoma to Acquire Generation Bio
Xoma Royalty, a company that has recently established a business strategy centered on acquiring distressed biotechnology firms, has secured its…
Read More » -
Sanofi Secures Deals for Novel Alzheimer’s Drug and Next-Generation Autoimmune Therapy
On December 15, 2025, Sanofi announced two significant strategic collaborations aimed at strengthening its advanced therapeutic development pipelines. 1. Agreement…
Read More » -
Major Pharmaceutical Company Lowers Revenue Forecast, Shares Drop
The global pharmaceutical corporation, Pfizer, has issued a revenue projection for 2026 in the range of $59.5 billion to $62.5…
Read More » -
New Biotech Startup Secures $125 Million to Advance Pain Medication
Ambros Therapeutics, a newly launched biotechnology company, debuted with an oversubscribed Series A financing round of $125 million. The firm…
Read More » -
Sanofi Signs Potential $1 Billion Deal for Alzheimer’s Antibody Asset
Sanofi has entered into a licensing agreement with Adel, a clinical-stage biotech based in Seoul, South Korea, for the development…
Read More » -
Alphyn Biologics Secures $25 Million in Series B Funding
Alphyn Biologics, a US-based biotechnology company, has successfully completed a Series B funding round, raising $25 million. The round was…
Read More » -
SOBI Agrees to Acquire Arthrosi Therapeutics
Swedish Orphan Biovitrum (SOBI) has reached an agreement to acquire Arthrosi Therapeutics Inc., a late-stage biotechnology company developing a highly…
Read More » -
Strategic Partnership Expanded Between Dren Bio and Sanofi for Next-Generation B-Cell Therapy
Dren Bio, a privately held, clinical-stage biotechnology company, announced an expanded strategic collaboration with Sanofi for the discovery and development…
Read More » -
PARP Combination Therapy Expands Treatment Indication in Prostate Cancer
The U.S. Food and Drug Administration (FDA) has granted an expanded approval for a targeted combination therapy for patients with…
Read More » -
J&J Multiple Myeloma Drug Regimen Receives Proactive National Priority Review Voucher from the FDA
The U.S. Food and Drug Administration (FDA) has “proactively” awarded Johnson & Johnson (J&J) a Commissioner’s National Priority Voucher (CNPV)…
Read More » -
Novel Combination Therapy Gains Initial Approval for Metastatic Breast Cancer Treatment
The U.S. Food and Drug Administration (FDA) recently granted approval for a new combination regimen for patients with unresectable or…
Read More » -
National Occupational Health Provider Extends Reach in Florida
Occupational health specialist Concentra (NYSE:CON), a publicly traded company, has expanded its national footprint by establishing a new medical center…
Read More » -
Strategic Collaboration Signed to Advance Metabolic Disorder Treatments
Zealand Pharma A/S and OTR Therapeutics have announced a strategic collaboration and license agreement focused on the discovery and development…
Read More » -
China’s NMPA Clears Two Sanofi Treatments for Rare Hematologic Diseases
China’s National Medical Products Administration (NMPA) has granted approvals for two of Sanofi’s rare hematologic disease treatments: Qfitlia (fitusiran) and…
Read More » -
European Union Advances New Pharmaceutical Regulatory Framework
Negotiators from the European Parliament (EP) and the EU Council have reached a provisional agreement on a new regulatory framework…
Read More » -
Novel Monoclonal Antibody Gains FDA Clearance for Generalized Myasthenia Gravis
The U.S. Food and Drug Administration (FDA) has granted an expanded indication for Amgen’s monoclonal antibody, Uplizna (inebilizumab). The new…
Read More » -
Regulator Authorizes New Oral Antibiotic Option for Gonorrhea
The U.S. Food and Drug Administration (FDA) has announced a decision to expand the usage approval for GSK’s antibiotic, Blujepa,…
Read More » -
Pharmaceutical Corporation Breaks Ground on Flagship US Production Center in North Carolina
EAST HANOVER, December 12, 2025 – The global pharmaceutical corporation Novartis has commenced construction on its major strategic manufacturing center…
Read More » -
Zydus Lifesciences and Formycon Partner to Supply Keytruda® Biosimilar for Cancer Patients in US and Canada
Zydus Lifesciences (India) and Formycon AG (Germany) have entered into an exclusive strategic partnership to license and supply FYB206, a…
Read More » -
Novartis and UK Biotech Relation Announce R&D Collaboration
Novartis, the major pharmaceutical corporation, has signed a multi-program research and development partnership agreement with Relation Therapeutics, an AI-driven biotech…
Read More »
